EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Prospects for liquid biopsy using microRNA and extracellular vesicles in breast cancer

Takahiro Ochiya, Kazuki Hashimoto, Akihiko Shimomura

Breast Cancer · 2025-01 · 32 (1) · 10-15

DOI: 10.1007/s12282-024-01563-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Breast Cancer, online erschienen am 30.03.2024. Verfasst von Takahiro Ochiya und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Medicine, Center for Future Medical Research, Institute of Medical Science, Tokyo Medical University, 6-7-1 Nish…. Hauptthemen laut MEDLINE: Breast Neoplasms, Extracellular Vesicles, MicroRNAs, Biomarkers, Tumor. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Among the analytes circulating in body fluids, microRNAs, a type of non-coding RNA and known to exist 2655 in primates, have attracted attention as a novel biomarker for cancer screening. MicroRNAs are signaling molecules with important gene expression regulatory functions that can simultaneously control many gene functions and multiple different pathways in living organisms. These microRNAs are transported in extracellular vesicles (EVs), which are lipid bilayers with 50–150 nm in diameter, and are used as communication tools between cells. Furthermore, the EVs that carry these microRNAs circulate in the bloodstream and have other important implications for understanding the pathogenesis and diagnosis of breast cancer. The greatest benefit from cancer screening is the reduction in breast cancer mortality rate through early detection. Other benefits include reduced incidence of breast cancer, improved quality of life, prognosis prediction, contribution to personalized medicine, and relative healthcare cost containment. This paper outlines the latest developments in liquid biopsy for breast cancer, especially focusing on microRNA and EV diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsExtracellular VesiclesMicroRNAsBiomarkers, TumorHumansLiquid BiopsyFemaleEarly Detection of CancerPrognosis

Stichwörter der Autor:innen

Extracellular vesiclesLiquid biopsyMicroRNA

Substanzen

MicroRNAsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Molecular and Cellular Medicine, Center for Future Medical Research, Institute of Medical Science, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjyuku-ku, Tokyo, 160-0023, Japan. tochiya@tokyo-med.ac.…
  • Department of Breast Surgery, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
  • Department of Breast and Medical Oncology, Genetic Medicine, General Medical Oncology, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.

Zitieren

APA

Ochiya, T., Hashimoto, K., & Shimomura, A. (2025). Prospects for liquid biopsy using microRNA and extracellular vesicles in breast cancer. Breast Cancer, 32(1), 10-15. https://doi.org/10.1007/s12282-024-01563-9

Vancouver

Ochiya T, Hashimoto K, Shimomura A. Prospects for liquid biopsy using microRNA and extracellular vesicles in breast cancer. Breast Cancer. 2025;32(1):10-15. doi:10.1007/s12282-024-01563-9

BibTeX
@article{Ochiya2025,
  author = {Ochiya, Takahiro and Hashimoto, Kazuki and Shimomura, Akihiko},
  title = {Prospects for liquid biopsy using microRNA and extracellular vesicles in breast cancer},
  journal = {Breast Cancer},
  year = {2025},
  volume = {32},
  number = {1},
  pages = {10--15},
  doi = {10.1007/s12282-024-01563-9}
}
Kostenlos starten →